The Journal of Toxicological Sciences

Recently, a novel culture system consisting of primary hepatocytes structured over a network of endothelial cells on the Engelbreth-Holm-Swarm (EHS) gel has been reported. This in vitro liver model on the EHS gel (IVLEHS) has been shown to maintain the expression of hepatic genes and their functional activity. Moreover, the IVLEHS was more sensitive to xenobiotics than hepatocyte monocultures, suggesting the potential utility of this culture system for compound hepatotoxicity screening. However, the effect of this three-dimensional structure formation on the cellular metabolic profile of hepatocytes in the IVLEHS is not well understood. To address this concern, we performed metabolome analysis using capillary electrophoresis-time of flight mass spectrometry. Between the IVLEHS and mono-cultured hepatocytes on the EHS gel, there was no significant difference in the levels of metabolites of the urea cycle and the tricarboxylic acid cycle, essential amino acids, and adenylate energy charge (AEC) which is an important indicator of cellular energy status. On the other hand, acetaminophen-dependent decrease of the AEC in the IVLEHS was greater than that in the monoculture, suggesting the higher sensitivity of IVLEHS to acetaminophen-induced hepatotoxicity which is caused by metabolic activation of this drug. Further analysis showed that the levels of taurocholate, one of the major conjugated bile acids, were higher in the IVLEHS than in the monoculture. Considering that the construction of the IVLEHS did not seem to disturb the major cellular metabolism, our findings would strengthen the concept that IVLEHS would have beneficial effects on the maintenance of hepatic functions.

[1]  Joachim Doll,et al.  Organization for Economic Cooperation and Development , 2021, International Organization.

[2]  J. Namieśnik,et al.  3-MCPD: A Worldwide Problem of Food Chemistry , 2016, Critical reviews in food science and nutrition.

[3]  K. Cassidy,et al.  Difference in the Pharmacokinetics and Hepatic Metabolism of Antidiabetic Drugs in Zucker Diabetic Fatty and Sprague-Dawley Rats , 2016, Drug Metabolism and Disposition.

[4]  L. Henry,et al.  Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes , 2016, Hepatology.

[5]  A. Nishikawa,et al.  Orally administered glycidol and its fatty acid esters as well as 3-MCPD fatty acid esters are metabolized to 3-MCPD in the F344 rat. , 2015, Regulatory toxicology and pharmacology : RTP.

[6]  Takao Ashikaga,et al.  Evaluation of combinations of in vitro sensitization test descriptors for the artificial neural network‐based risk assessment model of skin sensitization , 2015, Journal of applied toxicology : JAT.

[7]  Akos Vertes,et al.  Energy Charge, Redox State, and Metabolite Turnover in Single Human Hepatocytes Revealed by Capillary Microsampling Mass Spectrometry. , 2015, Analytical chemistry.

[8]  P. Gissen,et al.  Structural and functional hepatocyte polarity and liver disease , 2015, Journal of hepatology.

[9]  F. Wang,et al.  Obesity and iron deficiency: a quantitative meta‐analysis , 2015, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[10]  Derek LeRoith,et al.  Obesity and Diabetes: The Increased Risk of Cancer and Cancer-Related Mortality. , 2015, Physiological reviews.

[11]  N. Solomons,et al.  Iron metabolism in obesity: how interaction between homoeostatic mechanisms can interfere with their original purpose. Part I: underlying homoeostatic mechanisms of energy storage and iron metabolisms and their interaction. , 2015, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.

[12]  V. Venketaraman,et al.  Investigating the Causes for Decreased Levels of Glutathione in Individuals with Type II Diabetes , 2015, PloS one.

[13]  Petra S Kern,et al.  Assessing skin sensitization hazard in mice and men using non-animal test methods. , 2015, Regulatory toxicology and pharmacology : RTP.

[14]  Elizabeth M. Lancaster,et al.  Acetaminophen hepatotoxicity: an updated review , 2014, Archives of Toxicology.

[15]  Z. Szabo,et al.  Myelotoxicity of carboplatin is increased in vivo in db/db mice, the animal model of obesity-associated diabetes mellitus , 2015, Cancer Chemotherapy and Pharmacology.

[16]  M. Coen.  Metabolic phenotyping applied to pre-clinical and clinical studies of acetaminophen metabolism and hepatotoxicity , 2015, Drug metabolism reviews.

[17]  Robert Landsiedel,et al.  LuSens: a keratinocyte based ARE reporter gene assay for use in integrated testing strategies for skin sensitization hazard identification. , 2014, Toxicology in vitro : an international journal published in association with BIBRA.

[18]  Young-Man Cho,et al.  A 13-week subchronic toxicity study of ferric citrate in F344 rats. , 2014, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[19]  A. Xu,et al.  Adiponectin protects against acetaminophen-induced mitochondrial dysfunction and acute liver injury by promoting autophagy in mice. , 2014, Journal of hepatology.

[20]  C. Datz,et al.  Obesity as an Emerging Risk Factor for Iron Deficiency , 2014, Nutrients.

[21]  Tetsuro Suzuki,et al.  An in vitro liver model consisting of endothelial vascular networks surrounded by human hepatoma cell lines allows for improved hepatitis B virus replication. , 2014, Journal of bioscience and bioengineering.

[22]  T. Kasahara,et al.  Development of a prediction method for skin sensitization using novel cysteine and lysine derivatives. , 2014, Journal of pharmacological and toxicological methods.

[23]  A. Nishikawa,et al.  Absence of in vivo genotoxicity of 3-monochloropropane-1,2-diol and associated fatty acid esters in a 4-week comprehensive toxicity study using F344 gpt delta rats. , 2014, Mutagenesis.

[24]  William M. Lee,et al.  ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury , 2014, The American Journal of Gastroenterology.

[25]  L. Vitetta,et al.  Liver function parameters, cholesterol, and phospholipid α-linoleic acid are associated with adipokine levels in overweight and obese adults. , 2014, Nutrition research.

[26]  A. Nishikawa,et al.  A 13-week subchronic toxicity study of sodium iron chlorophyllin in F344 rats. , 2014, The Journal of toxicological sciences.

[27]  A. Nishikawa,et al.  A 13-week repeated dose study of three 3-monochloropropane-1,2-diol fatty acid esters in F344 rats , 2014, Archives of Toxicology.

[28]  R. Jover,et al.  Hepatic cell lines for drug hepatotoxicity testing: limitations and strategies to upgrade their metabolic competence by gene engineering. , 2013, Current drug metabolism.

[29]  K. Morishita,et al.  In vitro recapitulation of the urea cycle using murine embryonic stem cell-derived in vitro liver model , 2013, Amino Acids.

[30]  Adam S. Hayward,et al.  Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME , 2013, Archives of Toxicology.

[31]  Setsuya Aiba,et al.  Artificial neural network analysis of data from multiple in vitro assays for prediction of skin sensitization potency of chemicals. , 2013, Toxicology in vitro : an international journal published in association with BIBRA.

[32]  Z. Szilvássy,et al.  Toxicity of cytotoxic agents to granulocyte-macrophage progenitors is increased in obese Zucker and non-obese but insulin resistant Goto-Kakizaki rats. , 2012, European journal of pharmacology.

[33]  V. Karantza,et al.  The interplay between autophagy and ROS in tumorigenesis , 2012, Front. Oncol..

[34]  Yusuke Suzuki,et al.  Enhancement of acetaminophen-induced chronic hepatotoxicity in restricted fed rats: a nonclinical approach to acetaminophen-induced chronic hepatotoxicity in susceptible patients. , 2012, The Journal of toxicological sciences.

[35]  Xun Hu,et al.  Biochemical Issues in Estimation of Cytosolic Free NAD/NADH Ratio , 2012, PloS one.

[36]  Y. Igusa,et al.  Loss of autophagy promotes murine acetaminophen hepatotoxicity , 2012, Journal of Gastroenterology.

[37]  S. Oh,et al.  Hepatic expression of cytochrome P450 in type 2 diabetic Goto-Kakizaki rats. , 2012, Chemico-biological interactions.

[38]  T. Soga,et al.  Acetaminophen-Induced Hepatotoxicity in a Liver Tissue Model Consisting of Primary Hepatocytes Assembling around an Endothelial Cell Network , 2012, Drug Metabolism and Disposition.

[39]  H. Jaeschke,et al.  Activation of autophagy protects against acetaminophen‐induced hepatotoxicity , 2012, Hepatology.

[40]  G. Ammerer,et al.  Controlling gene expression in response to stress , 2011, Nature Reviews Genetics.

[41]  K. Shimoi,et al.  Effects of spaced feeding on gene expression of hepatic transaminase and gluconeogenic enzymes in rats. , 2011, The Journal of toxicological sciences.

[42]  Valérie Zuang,et al.  Alternative (non-animal) methods for cosmetics testing: current status and future prospects—2010 , 2011, Archives of Toxicology.

[43]  A. Lampen,et al.  Toxicological assessment of 3-chloropropane-1,2-diol and glycidol fatty acid esters in food. , 2011, Molecular nutrition & food research.

[44]  S. Aiba,et al.  Changes of cell-surface thiols and intracellular signaling in human monocytic cell line THP-1 treated with diphenylcyclopropenone. , 2010, The Journal of toxicological sciences.

[45]  P. Watkins,et al.  The Application of Metabonomics to Predict Drug‐Induced Liver Injury , 2010, Clinical pharmacology and therapeutics.

[46]  F. Wright,et al.  Use of Pharmaco‐Metabonomics for Early Prediction of Acetaminophen‐Induced Hepatotoxicity in Humans , 2010, Clinical pharmacology and therapeutics.

[47]  N. Chalasani,et al.  Risk factors for idiosyncratic drug-induced liver injury. , 2010, Gastroenterology.

[48]  J. Dorne,et al.  Metabolism, variability and risk assessment. , 2010, Toxicology.

[49]  Andreas Natsch,et al.  The Nrf2-Keap1-ARE toxicity pathway as a cellular sensor for skin sensitizers--functional relevance and a hypothesis on innate reactions to skin sensitizers. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[50]  D. Klionsky,et al.  Regulation mechanisms and signaling pathways of autophagy. , 2009, Annual review of genetics.

[51]  Amaya Aleixandre De Artiñano,et al.  Experimental rat models to study the metabolic syndrome. , 2009, The British journal of nutrition.

[52]  M. Yarmush,et al.  Oxygen-mediated enhancement of primary hepatocyte metabolism, functional polarization, gene expression, and drug clearance , 2009, Proceedings of the National Academy of Sciences.

[53]  Yusuke Suzuki,et al.  Effects of fenofibrate on plasma and hepatic transaminase activities and hepatic transaminase gene expression in rats. , 2009, The Journal of toxicological sciences.

[54]  Masaru Tomita,et al.  Metabolomic profiling of anionic metabolites by capillary electrophoresis mass spectrometry. , 2009, Analytical chemistry.

[55]  M. Tomita,et al.  Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. , 2009, Cancer research.

[56]  S. Aiba,et al.  Evaluation of changes of cell-surface thiols as a new biomarker for in vitro sensitization test. , 2009, Toxicology in vitro : an international journal published in association with BIBRA.

[57]  B. Viollet,et al.  AMP‐activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives , 2009, Acta physiologica.

[58]  S. Gibbs,et al.  Progress on the development of human in vitro dendritic cell based assays for assessment of the sensitizing potential of a compound. , 2009, Toxicology and applied pharmacology.

[59]  S. Aiba,et al.  Modification of cell-surface thiols elicits activation of human monocytic cell line THP-1: possible involvement in effect of haptens 2,4-dinitrochlorobenzene and nickel sulfate. , 2009, The Journal of toxicological sciences.

[60]  W. Tong,et al.  Evaluations of the trans-sulfuration pathway in multiple liver toxicity studies. , 2009, Toxicology and applied pharmacology.

[61]  H. Poulsen,et al.  Long-term administration of toxic doses of paracetamol (acetaminophen) to rats. , 2008, Liver.

[62]  Andreas Natsch,et al.  Skin sensitizers induce antioxidant response element dependent genes: application to the in vitro testing of the sensitization potential of chemicals. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[63]  Mina Choi,et al.  Carcinogenicity study of 3-monochloropropane-1,2-diol in Sprague-Dawley rats. , 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[64]  Wenqing Cai,et al.  Small molecule regulators of autophagy identified by an image-based high-throughput screen , 2007, Proceedings of the National Academy of Sciences.

[65]  V. Appanna,et al.  The Tricarboxylic Acid Cycle, an Ancient Metabolic Network with a Novel Twist , 2007, PloS one.

[66]  E. Schiff,et al.  Acetaminophen safety and hepatotoxicity – where do we go from here? , 2007, Expert opinion on drug safety.

[67]  G Frank Gerberick,et al.  Quantification of chemical peptide reactivity for screening contact allergens: a classification tree model approach. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[68]  G. Mitchell,et al.  Diagnostic accuracy of blood lactate-to-pyruvate molar ratio in the differential diagnosis of congenital lactic acidosis. , 2007, Clinical chemistry.

[69]  R. Rizzuto,et al.  Control of macroautophagy by calcium, calmodulin-dependent kinase kinase-beta, and Bcl-2. , 2007, Molecular cell.

[70]  C. Schneider,et al.  Calpain as a Novel Regulator of Autophagosome Formation , 2007, Autophagy.

[71]  Hayley S. Brown,et al.  Primary Hepatocytes: Current Understanding of the Regulation of Metabolic Enzymes and Transporter Proteins, and Pharmaceutical Practice for the Use of Hepatocytes in Metabolism, Enzyme Induction, Transporter, Clearance, and Hepatotoxicity Studies , 2007, Drug metabolism reviews.

[72]  K. Shankar,et al.  Mechanisms and Outcomes of Drug- and Toxicant-Induced Liver Toxicity in Diabetes , 2007, Critical reviews in toxicology.

[73]  H. Sakaguchi,et al.  Development of an in vitro skin sensitization test using human cell lines: the human Cell Line Activation Test (h-CLAT). I. Optimization of the h-CLAT protocol. , 2006, Toxicology in vitro : an international journal published in association with BIBRA.

[74]  H. Sakaguchi,et al.  Development of an in vitro skin sensitization test using human cell lines; human Cell Line Activation Test (h-CLAT). II. An inter-laboratory study of the h-CLAT. , 2006, Toxicology in vitro : an international journal published in association with BIBRA.

[75]  J. Sugatani,et al.  Changes in the expression of cytochromes P450 and nuclear receptors in the liver of genetically diabetic db/db mice. , 2006, Biological & pharmaceutical bulletin.

[76]  M. Tomita,et al.  Differential Metabolomics Reveals Ophthalmic Acid as an Oxidative Stress Biomarker Indicating Hepatic Glutathione Consumption* , 2006, Journal of Biological Chemistry.

[77]  Y. Nahmias,et al.  Endothelium-mediated hepatocyte recruitment in the establishment of liver-like tissue in vitro. , 2006, Tissue engineering.

[78]  Joseph K McLaughlin,et al.  Obesity and risk for chronic renal failure. , 2006, Journal of the American Society of Nephrology : JASN.

[79]  Ryutaro Hirose,et al.  Metabolic profiling of livers and blood from obese Zucker rats. , 2006, Journal of hepatology.

[80]  M. Murakami,et al.  CHARACTERIZATION OF CYTOCHROME P450 EXPRESSION IN MURINE EMBRYONIC STEM CELL-DERIVED HEPATIC TISSUE SYSTEM , 2006, Drug Metabolism and Disposition.

[81]  J. Lindon,et al.  Pharmaco-metabonomic phenotyping and personalized drug treatment , 2006, Nature.

[82]  Sharmilee P. Sawant,et al.  Protective Effect of Type 2 Diabetes on Acetaminophen-Induced Hepatotoxicity in Male Swiss-Webster Mice , 2006, Journal of Pharmacology and Experimental Therapeutics.

[83]  C. Roberts,et al.  Differential regulation of hepatic cytochrome P450 monooxygenases in streptozotocin-induced diabetic rats , 2006, Free radical research.

[84]  H. Kleinman,et al.  Matrigel: basement membrane matrix with biological activity. , 2005, Seminars in cancer biology.

[85]  S. Miyagawa,et al.  Crucial Roles of Mesodermal Cell Lineages in a Murine Embryonic Stem Cell–Derived In Vitro Liver Organogenesis System , 2005, Stem cells.

[86]  Neil Kaplowitz,et al.  Idiosyncratic drug hepatotoxicity , 2005, Nature Reviews Drug Discovery.

[87]  J. Miquel,et al.  Bile secretory function in the obese Zucker rat: evidence of cholestasis and altered canalicular transport function , 2004, Gut.

[88]  G Frank Gerberick,et al.  Development of a peptide reactivity assay for screening contact allergens. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[89]  Mi-Sook Kim,et al.  Differences in the pharmacokinetics of peroxisome proliferator-activated receptor agonists in genetically obese Zucker and sprague-dawley rats: implications of decreased glucuronidation in obese Zucker rats. , 2004, Drug metabolism and disposition: the biological fate of chemicals.

[90]  M. Estacion,et al.  Maitotoxin-induced cell death cascade in bovine aortic endothelial cells: divalent cation specificity and selectivity. , 2004, American journal of physiology. Cell physiology.

[91]  Y. Kanazawa,et al.  Chronological characterization of diabetes development in male Spontaneously Diabetic Torii rats. , 2004, Biochemical and biophysical research communications.

[92]  Jing Chen,et al.  The Metabolic Syndrome and Chronic Kidney Disease in U.S. Adults , 2004, Annals of Internal Medicine.

[93]  John C. Lindon,et al.  Hepatotoxin-induced hypercreatinaemia and hypercreatinuria: their relationship to one another, to liver damage and to weakened nutritional status , 2004, Archives of Toxicology.

[94]  R. Andrade,et al.  Drug-induced hepatotoxicity , 2003, The New England journal of medicine.

[95]  H. Jaeschke,et al.  The role of oxidant stress and reactive nitrogen species in acetaminophen hepatotoxicity. , 2003, Toxicology letters.

[96]  H. Kleinman,et al.  Role of the extracellular matrix in morphogenesis. , 2003, Current opinion in biotechnology.

[97]  M. Fellows,et al.  In vivo genotoxicity studies with 3-monochloropropan-1,2-diol. , 2003, Mutagenesis.

[98]  Jie Liu,et al.  Activation of PPAR‐α in streptozotocin‐induced diabetes is essential for resistance against acetaminophen toxicity , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[99]  K. Tan-No,et al.  Analgesic action of loperamide, an opioid agonist, and its blocking action on voltage-dependent Ca2+ channels , 2003, Neuroscience Research.

[100]  M. Tomita,et al.  Quantitative metabolome analysis using capillary electrophoresis mass spectrometry. , 2003, Journal of proteome research.

[101]  U. Apte,et al.  Type 1 diabetic mice are protected from acetaminophen hepatotoxicity. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[102]  L. Guarente,et al.  Nicotinamide adenine dinucleotide, a metabolic regulator of transcription, longevity and disease. , 2003, Current opinion in cell biology.

[103]  S. Nakagawa,et al.  p38 Mitogen-activated protein kinase and extracellular signal-regulated kinases play distinct roles in the activation of dendritic cells by two representative haptens, NiCl2 and 2,4-dinitrochlorobenzene. , 2003, The Journal of investigative dermatology.

[104]  R. Weindruch,et al.  Caloric restriction increases gluconeogenic and transaminase enzyme activities in mouse liver , 2003, Experimental Gerontology.

[105]  Masaru Tomita,et al.  Simultaneous determination of anionic intermediates for Bacillus subtilis metabolic pathways by capillary electrophoresis electrospray ionization mass spectrometry. , 2002, Analytical chemistry.

[106]  G. Forloni,et al.  Apoptotic Cell Death and Impairment of L-Type Voltage-Sensitive Calcium Channel Activity in Rat Cerebellar Granule Cells Treated with the Prion Protein Fragment 106–126 , 2000, Neurobiology of Disease.

[107]  P. O'Brien,et al.  Repeated acetaminophen dosing in rats: adaptation of hepatic antioxidant system , 2000, Human & experimental toxicology.

[108]  D R Saunders,et al.  Addressing human variability in risk assessment--the robustness of the intraspecies uncertainty factor. , 1999, Regulatory toxicology and pharmacology : RTP.

[109]  M L Yarmush,et al.  Effect of cell–cell interactions in preservation of cellular phenotype: cocultivation of hepatocytes and nonparenchymal cells , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[110]  J. Snawder,et al.  Repeat exposure to incremental doses of acetaminophen provides protection against acetaminophen‐induced lethality in mice: An explanation for high acetaminophen dosage in humans without hepatic injury , 1999, Hepatology.

[111]  A. Strain.  Ex vivo liver cell morphogenesis: One step nearer to the bioartificial liver? , 1999, Hepatology.

[112]  Y. Lazebnik,et al.  Caspases: enemies within. , 1998, Science.

[113]  S. Thamilselvan,et al.  Oxalate and calcium oxalate crystals are injurious to renal epithelial cells: results of in vivo and in vitro studies. , 1998, Journal of nephrology.

[114]  A G Renwick,et al.  Human variability and noncancer risk assessment--an analysis of the default uncertainty factor. , 1998, Regulatory toxicology and pharmacology : RTP.

[115]  G. Salvesen,et al.  Caspases: Intracellular Signaling by Proteolysis , 1997, Cell.

[116]  Y. Taniguchi,et al.  Severe Cutaneous and Venous Damage after DIC Therapy , 1997, The Journal of dermatology.

[117]  D. Malatjalian,et al.  Methotrexate hepatotoxicity in psoriatics: report of 104 patients from Nova Scotia, with analysis of risks from obesity, diabetes and alcohol consumption during long term follow-up. , 1996, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[118]  T. Pineau,et al.  Role of CYP2E1 in the Hepatotoxicity of Acetaminophen (*) , 1996, The Journal of Biological Chemistry.

[119]  C. Waterfield,et al.  Use of urinary taurine and creatine as biomarkers of organ dysfunction and metabolic perturbations , 1995, Comparative Haematology International.

[120]  P. McNamara,et al.  Effect of genetic obesity and phenobarbital treatment on the hepatic conjugation pathways. , 1993, The Journal of pharmacology and experimental therapeutics.

[121]  J. Watkins,et al.  Long-term diabetes alters the hepatobiliary clearance of acetaminophen, bilirubin and digoxin. , 1992, The Journal of pharmacology and experimental therapeutics.

[122]  D. Jackson,et al.  The extracellular matrix coordinately modulates liver transcription factors and hepatocyte morphology , 1991, Molecular and cellular biology.

[123]  H. Langford,et al.  Intravenous nicardipine for the treatment of severe hypertension. , 1988, The American journal of medicine.

[124]  H. Kleinman,et al.  Regulation of gene expression in adult rat hepatocytes cultured on a basement membrane matrix , 1988, Journal of cellular physiology.

[125]  C. Longcope,et al.  Serum testosterone and gonadotropins in the genetically obese male Zucker rat. , 1982, Endocrinology.

[126]  D. Jollow,et al.  Increased resistance of diabetic rats to acetaminophen-induced hepatotoxicity. , 1982, The Journal of pharmacology and experimental therapeutics.

[127]  W. Faulk,et al.  Propidium iodide as a nuclear marker in immunofluorescence. II. Use with cellular identification and viability studies. , 1981, Journal of immunological methods.

[128]  M. Younes,et al.  Studies on the mechanism of paracetamol-induced protection against paracetamol hepatotoxicity. , 1979, Toxicology.

[129]  R. Awadallah,et al.  Blood-reduced glutathione, pyruvic acid, citric acid, ceruloplasmin oxidase activity and certain mineral changes in diabetes mellitus before and after treatment , 1978, Zeitschrift fur Ernahrungswissenschaft.

[130]  H. Buttar,et al.  GLUTATHIONE ALTERATIONS IN RAT LIVER AFTER ACUTE AND SUBACUTE ORAL ADMINISTRATION OF PARACETAMOL , 1977, Clinical and experimental pharmacology & physiology.

[131]  H. Buttar,et al.  Serum enzyme activities and hepatic triglyceride levels in acute and subacute acetaminophen-treated rats. , 1976, Toxicology.

[132]  D. Kipnis,et al.  Alanine and glutamine synthesis and release from skeletal muscle. II. The precursor role of amino acids in alanine and glutamine synthesis. , 1976, The Journal of biological chemistry.

[133]  D. E. Atkinson,et al.  Adenylate Energy Charge in Escherichia coli During Growth and Starvation , 1971, Journal of bacteriology.

[134]  D. E. Atkinson.  The energy charge of the adenylate pool as a regulatory parameter. Interaction with feedback modifiers. , 1968, Biochemistry.

[135]  G. Leveille,et al.  In vivo and in vitro studies of gluconeogenesis in meal-fed and nibbling rats. , 1968, The Journal of nutrition.

[136]  H. Krebs,et al.  The redox state of free nicotinamide-adenine dinucleotide in the cytoplasm and mitochondria of rat liver. , 1967, The Biochemical journal.

[137]  S. Kumar,et al.  Effect of ketosis on the blood glutathione levels in the diabetic. , 1967, The Indian journal of medical research.

[138]  T. Zucker,et al.  FATTY, A NEW MUTATION IN THE RAT , 1961 .

[139]  R. D. Lawrence,et al.  Blood glutathione and non-glucose reducing substances in diabetes. , 1951, The Biochemical journal.

[140]  Heo Yong,et al.  ESAC Opinion on the BASF-coordinated Performance Standards-based validation of the LuSens test method for skin sensitisation testing , 2016 .

[141]  A. Guillouzo,et al.  General review on in vitro hepatocyte models and their applications. , 2010, Methods in molecular biology.

[142]  T. Yano,et al.  Characteristics of gabexate mesilate-induced cell injury in porcine aorta endothelial cells. , 2008, Journal of pharmacological sciences.

[143]  Esther F. Schmid,et al.  Drug withdrawals and the lessons within. , 2006, Current opinion in drug discovery & development.

[144]  G. Brabant,et al.  Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes. , 2000, Kidney international.

[145]  A. Puga,et al.  Regulation of gene expression by reactive oxygen. , 1999, Annual review of pharmacology and toxicology.

[146]  N. Stollman,et al.  Diagnosis and management of diverticular disease of the colon in adults. Ad Hoc Practice Parameters Committee of the American College of Gastroenterology. , 1999, The American journal of gastroenterology.

[147]  M. Toner,et al.  Microfabrication of Hepatocyte/Fibroblast Co‐cultures: Role of Homotypic Cell Interactions , 1998, Biotechnology progress.

[148]  J. Avorn.  Acetaminophen toxicity in an urban county hospital. , 1998, The New England journal of medicine.

[149]  D. Meyer,et al.  The CrmA- and TPCK-sensitive pathways that trigger oligonucleosome-sized DNA fragmentation in camptothecin-induced apoptosis: relation to caspase activation and high molecular weight DNA fragmentation. , 1997, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[150]  A. Meijer,et al.  The phosphatidylinositol 3-kinase inhibitors wortmannin and LY294002 inhibit autophagy in isolated rat hepatocytes. , 1997, European journal of biochemistry.

[151]  N. Vermeulen,et al.  Molecular aspects of paracetamol-induced hepatotoxicity and its mechanism-based prevention. , 1992, Drug metabolism reviews.

[152]  W. Haschek,et al.  The role of cytochrome P450IIE1 in bioactivation of acetaminophen in diabetic and acetone-treated mice. , 1991, Advances in experimental medicine and biology.

[153]  S. Clissold,et al.  Nicardipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in the treatment of angina pectoris, hypertension and related cardiovascular disorders. , 1987, Drugs.

[154]  J. Kerr,et al.  Apoptosis: Its nature and implications for dermatopathology , 1979, The American Journal of dermatopathology.